People being Taken against Their will in Human Trafficking

Human Trafficking – Politics The act of smuggling humans is an act that’s against the law, but it’s still being performed today. Although the government has been trying to stop human trafficking, it still an act that is going to most likely take years to nullify, since some victims fall for false hopes given to them by contractors, and some are sequestrated against their will. According to the U.S. State Department and the United Nations International Labor Organization – an estimated 2 and a half million individual generate thirty – two million dollar in profits every year. Siddharth Kara is an expert in economics and on human trafficking of Harvard University stated that even though roughly 4 % percent of the world’s slaves today are traffic sex slaves, they generate closely up to 40 % percent of the profits. So far, commercial sex trade is the segment mostly seen in modern slavery based on CNBC. And also, underage girls around Tijuana, whi ch is around a Mexican territory, are given false I.D.’s stating them as grown adults. Human trafficking for sex labor is a 28 billion dollar a year global industry. Human trafficking is now happening in Tampa Bay. The smuggling of humans takes an estimated 9 billion dollar in profits each year, and Florida falls in the top 3 destinations states for human trafficking. Kathlyn M. Mackvjack, a super attorney from the Immigration Unit Gulf coast Legal Services, stated that â€Å"sophisticated human traffickers useShow MoreRelatedThe Human Of Human Trafficking Epidemic1448 Words   |  6 PagesThe Human Trafficking Epidemic Introduction Dai is a victim of human trafficking. She became a victim when she met a military man and fell in love. He then convinced her to to move to a remote location with him. She agreed and once she got there, she was beaten and raped. She was eventually able to escape, but the man had taken all of her forms of identification. This meant that she was unable to really get any help or start a new life. From there she became a street walker to help make money soRead MoreThe Trafficking Of Human Trafficking1061 Words   |  5 Pagesin the world today. Unfortunately due to trafficking being a fast growing crime it is very difficult to identify and locate these organizations and victims. Although there are many groups created to support victims, not enough awareness is being made and not enough action is being applied to stop human trafficking. Sex trafficking is a form of human trafficking that has been a worldwide issue since ancient times, but regularly forgotten, due to it being almost an impossible to fix dilemma. SinceRead MoreHuman Trafficking : The Illegal Act Of Trading Humans1157 Words   |  5 PagesTH 2pm Final Draft Human trafficking is the illegal act of trading humans for any type of forced behavior, such as prostitution or labor. It is estimated by the United Nations that four million people around the world are victims of human trafficking each year. This global issue needs to be better controlled by foreign and domestic cooperation and awareness. One of the most important things to know about human trafficking is the different forms. While sexual human trafficking is the most commonRead MoreHuman Trafficking Is The Modern Form Of Enslavement1267 Words   |  6 PagesInitiatives on Human Trafficking Almost two centuries after the 16th President Abraham Lincoln issued the Emancipation Proclamation, a new type of slave trade has taken possession of the lives of many human beings worldwide. Human trafficking is the modern form of enslavement. It includes the purchasing and selling of individuals for forced labor or sexual abuse. This new type of enslavement of human beings is evident all around the world. Additionally, the number of enslaved victims today is surpassingRead MoreEssay about Human Trafficking in the United Kingdom1457 Words   |  6 PagesHuman trafficking is not just a part of our history; it is continuously growing around the world today because of traffickers who are using it as an easy way to make a profit. Victims of human trafficking feel as if they have no way to escape because they have limited ways to survive or make a good enough living to support themselves along with their families outside of the sex industry. Women, children and even men from time to tim e are taken before they get the opportunity to receive little ifRead MoreProtecting The Victims Of Human Trafficking Essay1676 Words   |  7 Pages Protecting the Victims Most people confuse the term human trafficking with human smuggling. Human smuggling is business transaction between two willing parties involving movement across borders, usually by illegal means. Human trafficking is the illegal movement of people, typically for the purposes of forced labor or commercial sexual exploitation. According to the Global Rescue Relief website, â€Å"The United States Department of State estimates that 800,000 women, children and men are internationallyRead MoreHuman Trafficking Is A Global Phenomenon902 Words   |  4 PagesIn a world with a little over 6 billion people, 27 million of them suffer from the injustice of human trafficking. Freedom. It s the thing we as all human being s strive for in life. The one thing we should all be promised when put into this world. To think that slavery is something that is over and done with would be an ignorant statement. Slavery is still happening at this very moment, just under our noses. When we think o f slavery we recall the African American slave trade that had presumablyRead MoreHuman Trafficking : A Dangerous Crime1634 Words   |  7 PagesHuman trafficking is the quickest increasing criminal industry currently in society and is a dark human behavior that has been going on since the beginning of history. The trafficking of human beings for forced slave labor and sexual exploitation is a horrendous crime that takes advantage of one throughout the illegal trading and forced labor of all types of people People trafficking forces millions of people going against their will and having to take part in prostitution, beg and complete hardRead MoreHuman Trafficking : Modern Day Slavery1531 Words   |  7 PagesHuman trafficking is modern day slavery that occurs with both genders of all ages. Human trafficking occurs mostly in poorer countries like Asia, and Eastern Europe and isn t solely sexual slavery; the victims can be used for labor purposes also. Organizations like Shared Hope International and Coalition Against Trafficking in Women fight to rescue the victims of human trafficking. These organizations spread the dangers of human trafficking through education and public awareness. Often times traffickingRead MoreHuman Trafficking Is A Serious Crime And An Unrefined Violation Of Human Rights1578 Words   |  7 PagesTrafficking in human beings is a serious crime and an unrefined violation of human rights. It is often linked to organized crime and is one of the most profitable criminal activities worldwide (Access to European Union Law, 2014). There are many different forms of human trafficking, and they progress with changing socioeconomic circumstances. It targets women and men, girls and boys in vulnerable positions (Trafficking in Human Beings, 2013). The International Labor Organization in June of 2012 covering

Evaluate the Strengths and Weaknesses of Reason as a Way...

Theory of knowledge | EVALUATE THE STRENGTHS AND WEAKNESSES OF REASON AS A WAY OF KNOWING | Word Count: 1,584 | | Reason is a priori. All humans are born with it. It is a way of knowing as it is used in every area of knowledge and in collaboration with the other ways of knowing. Unlike the implication of the prescribed essay topic, reason is not a distinctive way of knowing. To say that is an oversimplification of the complexity of knowing. Knowledge can only be obtained through the inextricably linked ways of knowing. Reason comes to us naturally. For example, we purposely choose to recall past experiences to apply it to new and similar experiences. Most people value reason over the other ways of knowing. For example, North†¦show more content†¦A physician fresh out of medical school may examine a patient several times because one set of symptoms could point to several different causes. Conversely, an experienced doctor may settle on one diagnosis immediately. In an emergency, this experienced doctor is valued for his â€Å"unreasonableness.† If the less experienced doctor was used, the patient coughing up blood profusely would probably die before a diagnosis was reached. Another example of reason not being an asset in science would be when science is turned into a faith, like eugenics, the â€Å"scientific† improvement of the human race. Until the arrival of the Nazis, eugenics was an accepted part of science. This twist on reason must be somehow regulated. This twist on reason must be somehow regulated, leading into the following comparison between reason and emotion as ways of knowing. As stated previously, most cultures view reason and emotion as opposites. The speed of emotional response is seen as inferior to the slower reasoned response. An instance of this might be deciding whether to walk out of a meeting because your ideas are put down, or to stay and attempt to justify your idea. Of course, the latter would be the better choice. However, in some cases, an emotional response may be the wiser choice. The classic yet strong and applicable example would be leaping back in the face of a dangerous situation such as a stalker suddenly approaching you. However this may also cause us to jumpShow MoreRelatedEvaluate the Strengths and Weaknesses of Reason as a Way of Knowing1484 Words   |  6 PagesThere are four main ways of knowing – reason, perception, language and emotion. However each one of them have their own strengths an d weaknesses and only by knowing them will we be able to better use these ways of knowing to gain knowledge. This essay will seek to examine the strengths and weaknesses of reason as a way of knowing. Reason is often seen as one of the most powerful ways of knowing – for it ‘seems to give us certainty’ (Lagemaat, 112). Reason uses logic to form arguments and conclusionsRead MoreWe Rely on All the Four Ways of Knowing; Sense of Perception, Language, Emotion and Reason. However, They All Have Weaknesses. We Often Use Ways of Knowing in Conjunction with Each Other. Some Areas of Knowledge Might1743 Words   |  7 PagesWe rely on all the four ways of knowing; sense of perception, language, emotion and reason. However, they all have weaknesses. We often use ways of knowing in conjunction with each other. Some areas of knowledge might not use sense of perception as such but we sometimes think that Maths for example uses mainly logic or reason. Is this true? Reason is one of the strongest ways of knowing. One of the strengths of reason as a source of knowledge is that it seems to give us certainty. We canRead MoreDiscussion Of Domain B Focuses On Evaluating The Student Learning As A Whole Process1592 Words   |  7 Pagesorder to become an effective and successful education specialist. To begin with, TPE 2 consists of different factors in performing the teaching job. First, teacher should demonstrates knowledge of confidentiality provisions and requirements. For this reason, teacher needs to make sure all personal and testing information are confidential. It can only be shared with IEP team who are involved in the student’s education. Second, teacher should demonstrate working knowledge of basic tests and measurementRead MoreImplementing Change1137 Words   |  5 Pages2006). One way to help ensure that the change will be successful is to involve the staff in the process; keeping in mind they may not be willing to accept the new regiment. There are multiple reasons why the staff may resist according to (NHS Modernization Agency, 2005). Staff may: †¢ Not be aware of the reasons why change is necessary †¢ Feel that there are other more important issues to be dealt with †¢ Not agree with the proposed change, or feel that there is a better way to achieve theRead MoreStrategic Readiness And Cultural Aptitude1627 Words   |  7 Pagesnegotiate in Chinese, creates a competitive advantage. Negotiations in China Negotiation are primarily a mechanism to build trust so that two parties can agree for the mutual benefit of both. Trust is gained by dialogue that lets each agent assess or evaluate the other and their capabilities. The negotiation process enables parties to come to an understanding on an issue or point that lets each side feel there’s a â€Å"win-win† for both. However, the concept of negotiation relies on establishing cooperationRead MoreContribute to the development of children and young people1048 Words   |  5 Pagesdevelopment needs of children and young people Outcome 1 – Be able to contribute to assessments of the development needs of children and young people (1.1) Share your EYFS assessment records and observations with your assessor For confidentiality reasons these records are kept in the office in a locked cabinet. Assessor to confirm that observations are carried out in all areas of development (1.2) List different observation methods and give and explanation of how they are used Diary: a daily recordRead MoreEvaluate Two Models of Disability in Terms of Explaining the Concept of Disability.1613 Words   |  7 PagesEvaluate two models of disability in terms of explaining the concept of disability. Medical model;-- Weaknesses;-- There are many weaknesses of the medical model. One of the weaknesses that I am going to talk about is that in some cases people see the medical model as an insult due to the fact that the model tries to ‘fix’ people with a disability instead of making adjustments and adaptions to environments, activities etc†¦ for them. Due to the fact that the medical model is trying to ‘fix’ tem, mayRead MorePersonal Strengths And Weaknesses Of Leadership1462 Words   |  6 PagesIntroduction Effective leaders need to evaluate themselves in order to uncover their points of strength and areas of weakness on a regular basis. Self-evaluation helps leaders to see how far they are from achieving goals. It also provides a guidance to plan for what needs to be improved on personal and professional aspects. Clawson stated that before trying to understand other people’s behavior and personality, a leader has to be able to understand the own behavior and the reason behind it in order to maximizeRead MoreThe Legal Team Of Greene s Jewelry Essay1692 Words   |  7 PagesWe the legal team of Greene’s Jewelry have the opportunity to evaluate all the necessary details of the case and overlooked what the strengths and weaknesses of our argument would be presented to the Court. To assist our argument we have decided to utilize the regulations, substantive laws and case laws. The case precedents will provide multiple directions for the arguments to be assessed in the Court. Greene’s Jewelry is more likely to receive a favorable judgment by applying these resources inRead MoreSwot Analysis : My Personal Swot1746 Words   |  7 Pagesspecific categories to evaluate a project, situation or in my case my personal and professional life (Hay, Castilla, 2006). In this analysis I will look at the strengths, weaknesses, opportunities, and threats that I need to address in my life. The concept of this type of analysis is a great way to find out ways to improve, but at the same time is a difficult task for someone like me who has a hard time outwardly expressing self attributes. That might be one of my weaknesses or threats, on the other

Cipla Free Essays

INTRODUCTION: Cipla Limited is an Indian pharmaceutical company, Founded by nationalist Indian scientist Khwaja Abdul Hamied as The Chemical, Industrial Pharmaceutical Laboratories . Cipla laid foundations for the Indian pharmaceutical industry way back in 1935 with the vision to make India self-reliant and self-sufficient in healthcare. Legacy of innovation and an entrepreneurial spirit ingrained by the founder, Dr. We will write a custom essay sample on Cipla or any similar topic only for you Order Now K. A Hamied and propounded by the present Chairman and Managing Director, Dr. Yusuf Khwaja Hamied . Over the past 77 years, Cipla has emerged as one of the most respected pharmaceutical names not just in India but worldwide. The company? s headquarter is in Mumbai, India. Cipla produces one of the widest range of products and dosage forms in the world today, everything from metered-dose inhalers, pre-filled syringes, trans-dermal spray patches, lyophilized injections, nasal sprays, medical devices, and thermo labile foams. The company Revenue is around 6977million and turnover is around 1 billion. Cipla? Business model is based on international strategic alliances and focus on pursuing organic growth while reducing capital commitment and regulatory/litigation risks. Cipla makes drugs to treat cardiovascular disease, arthritis, diabetes, weight control, depression and many other health conditions, and its products are distributed in virtually every country of the world. And probably best-known outside its home country for pioneering the manufacture of low-cost anti-AIDS drugs for HI V-positive patients in developing countries. It has played a similarly prominent role in expanding access to drugs to fight influenza, respiratory disease and cancer. Cipla has over 34 state-of-the-art manufacturing units which have been approved by various Ministries of Health and Regulatory Authorities like US FDA, WHO, MCC -South Africa, MHRAUK, TGA-Australia among others. In addition, Cipla? s manufacturing facilities are GCMP compliant in conformity with national and international standards. With over 2000 products in 65 therapeutic areas, Cipla? product portfolio comprises of Active Pharmaceutical Ingredients(APIs), Formulations for Human and Animal Healthcare and OTC products. Cipla has the technological powers of manufacturing products in most dosage forms across therapeutic categories, which offers the company a unique competitive advantage. Cipla has earned a name for maintaining world-class quality across all its products and services. With the dedication of its 20,000 employees, Cipla continues to support, improve a nd save millions of lives with its high-quality drugs and innovative devices and is focused towards its commitment. Cipla won Chemexcil Award excellence for exports in 1980, wins National award for successful commercialization of publicity funded RD in 1988. Cipla received the Thomson Reuters India Innovation Award in 2012. VISION: Cipla started with a vision to build a healthy India MISSSION OF THE COMPANY: To make the life of the patients better. CIPLA RESEARCH DEVELOPMENT CIPLA? S research capabilities are extensive, from Chemical Synthesis, Delivery Systems and Medical Devices to Process Engineering, Animal Health Products, Neutraceuticals and Biotechnology. Today, across 170 countries, there are millions of patients who get to use a Cipla product to prevent, to cure, or for relief from suffering. In their cure and relief lies th e ultimate purpose of what they do. At Cipla, this has been the driving force behind continuous quest for quality. The company strive not just to meet international specifications, but to exceed, to excel, to meet what they call the Cipla benchmark. In fact, they have set standards for the world to follow and have contributed to more than 125 monographs in the last 15 years – to British, European, US and international pharmacopoeia. Today companies from around the world seek strategic alliances with Cipla for product development, technical support and marketing. In a small way, the company even help countries set up their pharmaceutical infrastructure and train their professionals, contributing to their quest for self-reliance just the way they began healing India, seven decades ago. Equally inspiring has been Cipla? s fight against asthma. They partnered with the medical fraternity to shatter myths, spread awareness and empowered asthma patients to lead a fuller life. The company have the world’s largest range of asthma medication and delivery systems. This relentless commitment to asthma inspired to set up the Chest Research Foundation. It? s one of the few Institutes in the world that? s dedicated to clinical and allied research in the field of Chronic Respiratory Diseases. CHANGES In the past few years, Cipla has changed its strategy in a number of areas — from region, to product to human resources — to prevent a future meltdown from eroding margins. Till now, the names Cipla and Yusuf Hamied have been virtually interchangeable. After all, Hamied was the one who put the generic drug company onto the world map when he provided many health care systems in developing countries with cheaper versions of unaffordable AIDS drugs, making instant icons out of himself and his company . Today, however, Hamied is no longer steering the drug maker on a daily basis and Cipla, meanwhile, is engineering a quiet revolution on its own — attracting outside talent, which it has never done before — and venturing into new territory in order to avoid an existential crisis when the patent cliff expires in a few years. Simply put, the company has begun a quest for a growth trajectory that will generate sustainable profits in the future. â€Å"While we may call it a „transformation,? it is a reasonable and justifiable extension or next step to their current strengths†¦ The change is required to open new avenues of growth for the company, and not lose out on opportunities that come with a shelf life, particularly the patent cliff in 2012-17, for both small molecules and biologics,† says Aashish Mehra, managing director, Strategic Decision Group. Cipla? s recent reconceptualisation has boosted its stock price from Rs 317 in June to Rs 395 in September. Marketing itself Perhaps the biggest change in the company? s strategy is the jettisoning of its focus on volumeled growth and a shift to an inorganic, profitability-focused one. A key indication of this is the company? s willingness to move on to the front-end in developed markets like the US, where, so far, it has operated primarily through partners for sales and distribution of its products. Recently, Cipla started filing applications aggressively with the US Food and Drugs Administration (USFDA), seeking approval for its own generic products, which it plans to market on its own while assembling a separate sales team there. â€Å"The move is aimed at getting more value for products and technology,† says Cipla Director S Radhakrishnan in an interaction with Business Standard. This is a laudable move, say analysts, in a company that had the potential, but, it was so far unrealised. â€Å"Over the last few years, while all of Cipla? peers have grown primarily on the back of their success in the US market, Cipla had adopted a seemingly faulty strategic decision to limit its exposure to this market,† says a recent report on Cipla by IDFC Securities. â€Å"Given Cipla? s extensive product repertoire, proven RD capabilities and extensive manufacturing network, we believe it has all the ingredients to succeed in the US market despite its relatively late entry,â₠¬  it adds. (Cipla’s changing landscape) The change in strategy is not limited to just the US and other developed markets. The company is also actively planning joint ventures and even acquisitions to strengthen its position in key markets like Turkey, Morocco, Brazil and Nigeria. However, company insiders suggest that transformation does not necessarily mean a complete departure from its present approach. â€Å"The spirit of the company cannot change, at least not entirely. We will continue with our basic mantra of low-cost drug making,† says the Cipla official. â€Å"We are also looking at consolidation with partners as one of the options in some key markets,† he adds. This can probably explain what Cipla has recently done in China. In order to streamline investments there, the company has rejigged its business in order to focus more on its core areas. While the drug maker has exited a significant part of its investment in Chinese partner Desano Holdings, it has ploughed part of the funds into specific units that manufacture biosimilars and niche active pharmaceutical ingredients (APIs). The quest for higher margins An imminent revolution can be seen in Cipla? s product portfolio. The company is gradually shifting focus to high-margin products, such as oncology drugs and inhalers from tender-based anti-retroviral medicines. No surprise as to why it is doing so — its margins are slated to halve themselves from 21. 3 per cent in FY10 to an estimated 11. 9 per cent in FY14. According to Mehra, Cipla may perhaps be best known outside India by its landmark low-priced, anti-HIV products, but, it also needs to address regulated markets with quality products, across segments. â€Å"Cipla should rightly be proud of its image of being a „low-cost drug maker? ut the anti-retrovirals had been quite low-margin for Cipla, and changing the product mix towards more high-value products, such as the inhalers for the regulated markets, would help shore up margins,† says Mehra. Praful Bohra, senior analyst at Nirmal Bang Securities, says two years ago, the contribution from anti-retroviral drugs was 20-25 per cent while today, it has fallen to 15 per cent. Acc ording to analysts, the falling margins in anti-retroviral drugs due to tough competition from multinational, as well as domestic companies has triggered the shift towards new avenues. Regional shift The rationalisation can also be viewed through the export contribution from different geographies. According to the IDFC report, contribution of Africa — which is primarily a tender business market — to total exports declined from 42 per cent in the financial year 2010-11 to 40 per cent in 2011-12, with absolute sales remaining flat, year-on-year. In contrast, the share of Europe and Australasia grew from 26 per cent in financial year 2010-11 to 30 per cent in 201112 with sales growing at 32 per cent and 18 per cent, respectively. Cipla also plans to increase its focus on domestic markets, with introduction of its offerings in new therapeutic segments, such as oncology and neuropsychiatry. â€Å"The company is the market leader in key therapeutic areas, such as respiratory care, anti-viral and urological†¦ Cipla plans to focus on growing its market share and sales by increasing penetration in the Indian market, especially in rural areas,† a recent report by Angel Broking said. The company? s distribution network in India consists of a field force of around 7,000 employees. The company? new offerings would also include biosimilars, especially those in the oncology, anti-asthmatic and anti-arthritis categories. â€Å"They already have the pipeline in place (Avastin, Herceptin, Enbrel, among others), and would benefit from having the commercial footprint in regulated markets at the earliest,† points Mehra. Cipla has already invested $165 million in India and China to acquire facilities and buil d new ones for its foray. The company? s earnings in the first quarter of the financial year 2012-13 have begun to demonstrate the potential of these initiatives. During the financial quarter ended June 2011, the company? s gross margin expanded by 490 bps, year-on-year, to 61. 8 per cent, mainly on account of a better product mix, which had lower proportion of anti-retroviral in formulation exports and higher proportion of domestic formulation sales. â€Å"Strengthening of the balance sheet has been a key focus area for Cipla in the last few years and the benefits of concentrated efforts are clearly visible,† says Nitin Agarwal of IDFC. People Possibly the biggest catalyst of the change that Cipla is going through is because of a radical new strategy regarding management hires. Cipla has traditionally not been aggressive about hiring senior management personnel from outside the organisation. However, there seems to be a clear change in strategy on this front, reflective of the transformation underway into a more aggressive unit,† says Agarwal in the report. According to Bohra, this also reflects increasing professionalism in the company, which is also essential to surviving cut-throat competition in the industry. Over the past year, Cipla has hired people in the key functions of finance, international business and strategy, from competitors such as Lupin and Dr Reddy? . In July, Cipla announced the hiring of Frank Peters (ex-Teva and GSK) to head its respiratory business and the European Union region. Also, two Hamied scions — Kamil (31) and Samina (36), children of Yusuf Hamied? s brother M K Hamied — are on Cipla? s senior management team since 2010 and 2011, respectively. Analysts see this as an attempt to address key investor concerns on succession planning. These are key moves that were long overdue for a company that is yet to harness its full potential. How to cite Cipla, Essay examples